For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Placement of these bioresorbable devices enable individuals to live with a normal functioning artery as well as the option to undergo an angioplasty in their later years. While still in development stage, the pediatric patient cohort with genetic coronary conditions are a viable target for these fully dissolvable stents that allow restoration of normal vasomotor function as well as normal vessel growth.
Scope of the Report:
This report studies the Bioresorbable Coronary Stents market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bioresorbable Coronary Stents market by product type and applications/end industries.
APAC is expected to witness the fastest growth with a CAGR of 21%. Apart from increasing coronary stenting procedure volumes that stem from the high CVD-afflicted patient count, this region witnesses quick uptake of CE and FDA-approved devices, which in turn is engendering the high sales revenue of bioresorbable coronary stents in this regional segment.
The global Bioresorbable Coronary Stents market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bioresorbable Coronary Stents.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
- BIOTRONIK
- Meril Lifesciences Pvt. Ltd.
- Elixir Medical Corporation
- REVA Medical
- Arterial Remodeling Technologies
- Amaranth Medical
- Microport Scientific Corporation
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Absorb BVS
- Absorb 2nd Generation
- Magmaris
- Magnitude
- MeRes-100
- DESolve
Market Segment by Applications, can be divided into
- Hospital
- Clinic
- Research Institute